Management Issues in Toxicology

ABSTRACT

The lack of evidence-based information in toxicology results in debate and differing recommendations on management issues. Gastric lavage is often utilized to remove toxins from the stomach but a clinical benefit of the procedure has not been definitively demonstrated. A selective approach is warranted in each patient, and gastric lavage can be considered in patients with life-threatening ingestions if it can be performed within 60 minutes of ingestion. Whole bowel irrigation is a method of GI decontamination utilizing isotonic electrolyte solution. Although safe, there is currently insufficient data to establish definite indications for use. This technique can be considered for potentially toxic ingestions of lithium, iron, and sustained-release or enteric-coated drugs. Multiple-dose activated charcoal has been used to enhance elimination of drugs already absorbed into the body but the optimum dose and frequency of administration is not established. Based on volunteer studies and limited clinical reports, multiple-dose activated charcoal may be considered in patients with life-threatening ingestions of carbamazepine, dapsone, phenobarbital, quinine, or theophylline. A variety of interventions in addition to hemodialysis have been proposed to enhance lithium elimination. Forced saline diuresis and diuretics are not indicated. Although studies suggest that sodium polystyrene sulfonate may enhance elimination of lithium, no beneficial effects on clinical outcomes have been demonstrated and potential complications include hypokalemia and hypernatremia. Blood alkalinization for cyclic antidepressant toxicity has become standard therapy. Alkalinization is most effective in treating significant cardiac toxicity. Sodium bicarbonate, rather than hyperventilation, should be used initially to alkalinize blood. The benefit of blood alkalinization in the treatment of hypotension and seizures is not established.

KEYWORD

Toxicology - gastric lavage - whole bowel irrigation - lithium - activated charcoal - cyclic antidepressants

REFERENCES

• 1 Comstock E G, Faulkner T P, Boisaubin E V. Studies on the efficacy of gastric lavage as practiced in a large metropolitan hospital.  Clin Toxicol . 1981;  18 581-597
• 2 Arnold F J, Hodges J B, Barta B A. Evaluation of the efficacy of lavage and induced emesis in treatment of salicylate poisoning.  Pediatrics . 1959;  23 286-301
• 3 Tandberg D, Diven B G, McLeod J W. Ipecac-induced emesis versus gastric lavage: a controlled study in normal adults.  Ann Emerg Med . 1986;  4 205-209
• 4 Tenenbein M, Cohen S, Sitar D S. Efficacy of ipecac-induced emesis, orogastric lavage, and activated charcoal for acute drug overdose.  Ann Emerg Med . 1987;  16 838-841
• 5 Young W F, Bivins H G. Evaluation of gastric emptying using radionuclides: gastric lavage versus ipecac-induced emesis.  Ann Emerg Med . 1993;  22 1423-1427
• 6 Saetta J P, March S, Gaunt M E, Quinton D N. Gastric emptying procedures in the self-poisoned patient: are we forcing gastric content beyond the pylorus?.  J Roy Soc Med . 1991;  84 274-276
• 7 Kulig K, Bar-Or D, Cantrill S V. Management of acutely poisoned patients without gastric emptying.  Ann Emerg Med . 1985;  14 562-567
• 8 Pond S M, Lewis-Driver D J, Williams G M. Gastric emptying in acute overdose: a prospective randomised controlled trial.  Med J Aust . 1995;  163 345-349
• 9 American Academy of Clinical Toxicology, European Association of Poisons Centres and Clinical Toxicologists. Position statement: gastric lavage.  J Toxicol Clin Toxicol . 1997;  35 711-719
• 10 Smilkstein M J. Techniques used to prevent gastrointestinal absorption of toxic compounds. In: Goldfrank LR, Flomenbaum NE, Lewin NA, et al, eds. Goldfrank's Toxicologic Emergencies 6th ed. Stamford, CT: Appleton and Lange 1998: 35-51
• 11 Thompson A M, Robins J B, Prescott L F. Changes in cardiorespiratory function during gastric lavage for drug overdose.  Human Toxicol . 1987;  6 215-218
• 12 Kirshenbaum L A, Sitar D S, Tenenbein M. Interaction between whole-bowel irrigation solution and activated charcoal: implications for the treatment of toxic ingestions.  Ann Emerg Med . 1990;  19 1129-1132
• 13 Hoffman R S, Chiang W K, Howland M A. Theophylline desorption from activated charcoal caused by whole bowel irrigation solution.  J Toxicol Clin Toxicol . 1991;  29 191-201
• 14 Arimori K, Deshimaru M, Furukawa E, Nakano M. Adsorption of imipramine onto activated charcoal and a cation exchange resin in macrogol-electrolyte solution.  Chem Pharm Bull . 1992;  40 3105-3107
• 15 Tenenbein M, Cohen S, Sitar D S. Whole bowel irrigation as a decontamination procedure after acute drug overdose.  Arch Int Med . 1987;  147 905-907
• 16 Kirshenbaum L A, Mathews S C, Sitar D S, Tenenbein M. Whole-bowel irrigation versus activated charcoal in sorbitol for the ingestion of modified-release pharmaceuticals.  Clin Pharmacol Ther . 1989;  46 264-271
• 17 Smith S W, Ling L J, Halstenson C E. Whole-bowel irrigation as a treatment for acute lithium overdose.  Ann Emerg Med . 1991;  20 536-539
• 18 Mayer A L, Sitar D S, Tenenbein M. Multiple-dose charcoal and whole-bowel irrigation do not increase clearance of absorbed salicylates.  Arch Intern Med . 1992;  152 393-396
• 19 Rosenberg P J, Livingstone D J, McLellan B A. Effects of whole-bowel irrigation on the antidotal efficacy of oral activated charcoal.  Ann Emerg Med . 1988;  17 681-683
• 20 Kaczorowski J M, Wax P M. Five days of whole-bowel irrigation in a case of pediatric iron ingestion.  Ann Emerg Med . 1996;  27 258-263
• 21 Scharman E J, Lemberski R, Krenzelok E P. Efficiency of whole bowel irrigation with and without metoclopramide treatment.  Am J Emerg Med . 1994;  12 302-305
• 22 American Academy of Clinical Toxicology, European Association of Poisons Centres and Clinical Toxicologists. Position statement: whole bowel irrigation.  J Toxicol Clin Toxicol . 1997;  35 753-762
• 23 Campbell J W, Chyka P A. Physicochemical characteristics of drugs and response to repeat-dose activated charcoal.  Am J Emerg Med . 1992;  10 208-210
• 24 Ilkhanipour K, Yealy D M, Krenzelok E P. The comparative efficacy of various multiple-dose activated charcoal regimens.  Am J Emerg Med . 1992;  10 298-300
• 25 American Academy of Clinical Toxicology, European Association of Poisons Centres and Clinical Toxicologists. Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning.  J Toxicol Clin Toxicol . 1999;  37 731-751
• 26 Bradberry S M, Vale J. Multiple-dose activated charcoal: a review of relevant clinical studies.  J Toxicol Clin Toxicol . 1995;  33 407-416
• 27 Swartz C M, Sherman A. The treatment of tricyclic antidepressant overdose with repeated charcoal.  J Clin Psychopharmacol . 1984;  4 336-340
• 28 Howland M A. Activated charcoal. In: Goldfrank LR, Flomenbaum NE, Lewin NA, et al, eds. Goldfrank's Toxicologic Emergencies 6th ed Stamford, CT: Appleton and Lange 1998: 527-534
• 29 Scharman E. Methods used to decrease lithium absorption or enhance elimination.  J Toxicol Clin Toxicol . 1997;  35 601-608
• 30 Hansen H E, Amdisen A. Lithium intoxication (Report of 23 cases and review of 100 cases from the literature).  J Med . 1978;  186 123-144
• 31 Linakis J G, Lacouture P G, Eisenberg M S. Administration of activated charcoal or sodium polystyrene sulfonate (Kayexalate) as gastric decontamination for lithium intoxication: an animal model.  Pharmacol Toxicol . 1989;  65 387-389
• 32 Linakis J G, Hull K M, Lacouture P G. Enhancement of lithium elimination by multiple-dose sodium polystyrene sulfonate.  Acad Emerg Med . 1997;  4 175-178
• 33 Belanger D R, Tierney M G, Dickinson G. Effect of polystyrene sulfonate on lithium bioavailability.  Ann Emerg Med . 1992;  21 1312-1315
• 34 Gehrke J C, Watling S M, Gehrke C W, Zumwalt R. In-vivo binding of lithium using the cation exchange resin sodium polystyrene sulfonate.  Am J Emerg Med . 1996;  14 37-38
• 35 Linakis J G, Hull K M, Lacouture P G. Sodium polystyrene sulfonate treatment for lithium toxicity: effects on serum potassium concentrations.  Acad Emerg Med . 1996;  3 333-337
• 36 Pentel P R, Benowitz N L. Efficacy and mechanism of action of sodium bicarbonate in the treatment of desipramine toxicity in rats.  J Pharmacol Exp Ther . 1984;  230 12-19
• 37 Boehnert M, Lovejoy F H. Value of the QRS duration versus the serum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants.  N Eng J Med . 1985;  313 474-479
• 38 Hoffman J R, Votey S R, Bayer M, Silver L. Effect of sodium bicarbonate in the treatment of moderate-to-severe cyclic antidepressant overdose.  Am J Emerg Med . 1993;  11 336-341
• 39 Kingston M E. Hyperventilation in tricyclic antidepressant poisoning.  Crit Care Med . 1979;  550-551
• 40 Pentel P R, Benowitz N L. Tricyclic antidepressant poisoning: management of arrhythmias.  Med Toxicol . 1986;  1 101-121
• 41 Stone C K, Kraemer C M, Carroll R, Low R. Does a sodium-free buffer affect QRS width in experimental amitriptyline overdose?.  Ann Emerg Med . 1995;  26 58-64
• 42 McCabe J L, Cobaugh D J, Menegazzi J J, Fata J. Experimental tricyclic antidepressant toxicity: a randomized, controlled comparison of hypertonic saline solution, sodium bicarbonate and hyperventilation.  Ann Emerg Med . 1998;  32 329-333